Stage distribution of breast cancer diagnosed before and after implementation of population-based mammographic screening

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 184, Issue 5, 2012, Pages 437-442

  Hofvind, S ^a   Skaane, P ^b  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

breast; mammography; screening

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CHI SQUARE DISTRIBUTION; ECOLOGY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL;

AGED; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MIDDLE AGED; MORTALITY; NEOPLASM STAGING; NORWAY;

EID: 84860557706     PISSN: 14389029     EISSN: 14389010     Source Type: Journal    
DOI: 10.1055/s-0031-1299352     Document Type: Article

References (33)

1. Perry N, Broeders M, deWolf C et al. European guidelines for quality assurance in breast cancer screening and diagnosis. 4th ed European Communities. Luxemburg Office for Official Publications of the European Communities: 2006; 92-79-01258-4 http://bookshop.eu.int
2. Vainio H, Bianchini F. (eds) IARC Handbook of Cancer Prevention. Volume 7: Breast Cancer Screening. France, Lyon IARCPress: 2002; http://www.iarc.fr
3. Tabr L, Vitak B, Chen HH et al. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am: 2000; 38 625 651 (Pubitemid 30640056)
4. Nystrom L, Andersson I, Bjurstam N et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet: 2002; 359 909 919 (Pubitemid 34246378)
5. Moss SM, Cuckle H, Evans A et al. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet: 2006; 368 2053 2060 (Pubitemid 44855105)
6. Tabar L, Yen MF, Vitak B et al. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet: 2003; 361 1405 1410 (Pubitemid 36515039)
7. Paap E, Holland R, den Heeten GJ et al. A remarkable reduction of breast cancer deaths in screened versus unscreened women: a case-referent study. Cancer Causes Control: 2010; 21 1569 1573
8. Swedish Organised Service Screening Evaluation Group Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev: 2006; 15 45 51
9. Olsen AH, Njor SH, Vejborg I et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ: 2005; 330 220 225
10. Larsen IK, Smastuen M, Johannesen TB et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer: 2009; 45 1218 1231
11. Regulations on the collection and processing of personal health data in the Cancer Registry of Norway (Cancer Registry Regulations). http://www.lovdata.no
12. Hofvind S, Geller B, Vacek PM et al. Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program. Eur J Epidemiol: 2007; 22 447 455 (Pubitemid 47222954)
13. Cancer Registry of Norway Cancer statistics. http://kreftregisteret.no/ no/Registrene/Kreftstatistikk
14. Hofvind S, Sakshaug S, Ursin G et al. Breast cancer incidence trends in Norway - explained by hormone therapy or mammographic screening? Int J Cancer: 2011; (in press)
15. Lambe M, Wigertz A, Holmqvist M et al. Reductions in use of hormone replacement therapy: effects on Swedish breast cancer incidence trends only seen after several years. Breast Cancer Res Treat: 2010; 121 679 683
16. Skaane P. Studies comparing screen-film mammography and full-field digital mammography in breast cancer screening: updated review. Acta Radiol: 2009; 50 3 14
17. Jacobsen GD, Jacobsen KH. Health awareness campaigns and diagnosis rates: evidence from National Breast Cancer Awareness Month. J Health Econ: 2011; 30 55 61
18. Zahl PH, Gtzsche PC, Mhlen J. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study. Lancet Oncol: 2010; 12 1118 1124
19. Jrgensen KJ, Zahl PH, Gtzsche PC. Overdiagnosis in organised mammography screening in Denmark. A comparative study. BMC Womens Health: 2009; 22 36
20. Puliti D, Miccinesi G, Paci E. Overdiagnosis in breast cancer: design and methods of estimation in observational studies. Prev Med: 2011; 53 131 133
21. Ernster VL, Ballard-Barbash R, Barlow WE et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst: 2002; 16 1546 1554 (Pubitemid 35277278)
22. Srum R, Hofvind S, Skaane P et al. Trends in incidence of ductal carcinoma in situ: the effect of a population-based screening programme. Breast: 2010; 19 499 505
23. Duffy SW, Agbaje O, Tabar L et al. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res: 2005; 7 258 265 (Pubitemid 41830164)
24. Lynge E, Braaten T, Njor SH et al. Mammography activity in Norway 1983 to 2008. Acta Oncol: 2011; 50 1062 1067
25. Holleczek B, Arndt V, Stegmaier C et al. Trends in breast cancer survival in Germany from 1976 to 2008-A period analysis by age and stage. Cancer Epidemiol: 2011; 35 399 406
26. Kalager M, Zelen M, Langmark F et al. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med: 2010; 363 1203 1210
27. Skaane P. Nationwide mammography screening registers: the best way to go for mortality evaluation - but there is no free lunch. Acta Radiol: 2011; 52 235
28. van Ravesteyn NT, Heijnsdijk EA, de Koning HJ. More on screening mammography. N Engl J Med: 2011; 364 282 283
29. Duffy SW, Smith RA. More on screening mammography. N Engl J Med: 2011; 364 283 286
30. Green BB, Taplin SH. Breast cancer screening controversies. J Am Board Fam Pract: 2003; 16 233 241
31. Olsen AH, Njor SH, Lynge E. Estimating the benefits of mammography screening: the impact of study design. Epidemiology: 2007; 18 487 492 (Pubitemid 46955316)
32. Holmberg L, Duffy SW, Yen AM et al. Differences in endpoints between the Swedish W-E (two county) trial of mammographic screening and the Swedish overview: methodological consequences. J Med Screen: 2009; 16 73 80
33. Gtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev: 2011; CD001877. Review